Zobrazeno 1 - 10
of 103
pro vyhledávání: '"Anna, Lundgren"'
Autor:
Marjahan Akhtar, Salima Raiyan Basher, Nuder Nower Nizam, Lazina Hossain, Taufiqur Rahman Bhuiyan, Firdausi Qadri, Anna Lundgren
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
BackgroundInfection with enterotoxigenic Escherichia coli (ETEC) gives rise to IgA antibodies against both the heat labile toxin (LT) and colonization factors (CFs), which are considered to synergistically protect against ETEC diarrhea. Since the dev
Externí odkaz:
https://doaj.org/article/4bae8c357436484892694c6a93d40e2b
Autor:
Nikita Dutta, Anna Rohlin, Ella A. Eklund, Maria K. Magnusson, Frida Nilsson, Levent M. Akyürek, Per Torstensson, Volkan I. Sayin, Anna Lundgren, Andreas Hallqvist, Sukanya Raghavan
Publikováno v:
Frontiers in Oncology, Vol 12 (2023)
ObjectivesImmunotherapy by blocking programmed death protein-1 (PD-1) or programmed death protein-ligand1 (PD-L1) with antibodies (PD-1 blockade) has revolutionized treatment options for patients with non-small cell lung cancer (NSCLC). However, the
Externí odkaz:
https://doaj.org/article/ad6b94c7e52544b99cb293b558c87c00
Autor:
Lydia Scharf, Hannes Axelsson, Aikaterini Emmanouilidi, Nimitha R. Mathew, Daniel J. Sheward, Susannah Leach, Pauline Isakson, Ilya V. Smirnov, Emelie Marklund, Nicolae Miron, Lars-Magnus Andersson, Magnus Gisslén, Ben Murrell, Anna Lundgren, Mats Bemark, Davide Angeletti
Publikováno v:
JCI Insight, Vol 8, Iss 1 (2023)
Understanding persistence and evolution of B cell clones after COVID-19 infection and vaccination is crucial for predicting responses against emerging viral variants and optimizing vaccines. Here, we collected longitudinal samples from patients with
Externí odkaz:
https://doaj.org/article/3af8f63320a84aac8da92ced88e27ffa
Autor:
Verena Sengpiel, Ylva Carlsson, Jan‐Åke Liljeqvist, Anders Elfvin, Ing‐Marie Fyhr, Anna Lundgren, Kristina Nyström, Mats Bemark, Magnus Gisslen, Johan Ringlander
Publikováno v:
Clinical Case Reports, Vol 10, Iss 2, Pp n/a-n/a (2022)
Abstract Pregnancy might impact immunity after SARS‐CoV‐2 infection and/or vaccination. We describe the first case of reinfection with SARS‐CoV‐2 during a pregnancy. While the mother lacked detectable antibodies 2 months after the first infec
Externí odkaz:
https://doaj.org/article/5330825dbba54cdfa7764f6b1eddd3f0
Autor:
Emelie Marklund, Susannah Leach, Kristina Nyström, Anna Lundgren, Jan-Åke Liljeqvist, Staffan Nilsson, Aylin Yilmaz, Lars-Magnus Andersson, Mats Bemark, Magnus Gisslén
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
BackgroundThe risk of SARS-CoV-2 infection among health care workers (HCWs) is a concern, but studies that conclusively determine whether HCWs are over-represented remain limited. Furthermore, methods used to confirm past infection vary and the immun
Externí odkaz:
https://doaj.org/article/b7b556cbfa764bcba98caabde0a62b0e
Autor:
Marjahan Akhtar, Nuder Nower Nizam, Salima Raiyan Basher, Lazina Hossain, Sarmin Akter, Taufiqur Rahman Bhuiyan, Firdausi Qadri, Anna Lundgren
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Enhancement of mucosal immune responses in children and infants using novel adjuvants such as double mutant heat labile toxin (dmLT) is an important goal in the enteric vaccine field. dmLT has been shown to enhance mucosal IgA responses to the oral i
Externí odkaz:
https://doaj.org/article/b5e72a0e4b1b4010947f82a683808560
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Vaccines against enteric diseases could improve global health. Despite this, only a few oral vaccines are currently available for human use. One way to facilitate such vaccine development could be to identify a practical and relatively low cost bioma
Externí odkaz:
https://doaj.org/article/d6336b15ffed43fa9aed7b28c58267e1
Autor:
Emelie Marklund, Susannah Leach, Hannes Axelsson, Kristina Nyström, Heléne Norder, Mats Bemark, Davide Angeletti, Anna Lundgren, Staffan Nilsson, Lars-Magnus Andersson, Aylin Yilmaz, Magnus Lindh, Jan-Åke Liljeqvist, Magnus Gisslén
Publikováno v:
PLoS ONE, Vol 16, Iss 10, p e0258401 (2021)
[This corrects the article DOI: 10.1371/journal.pone.0241104.].
Externí odkaz:
https://doaj.org/article/060465cf75c84a24b4c8d399cd4ea4d3
Autor:
Emelie Marklund, Susannah Leach, Hannes Axelsson, Kristina Nyström, Heléne Norder, Mats Bemark, Davide Angeletti, Anna Lundgren, Staffan Nilsson, Lars-Magnus Andersson, Aylin Yilmaz, Magnus Lindh, Jan-Åke Liljeqvist, Magnus Gisslén
Publikováno v:
PLoS ONE, Vol 15, Iss 10, p e0241104 (2020)
BackgroundTo accurately interpret COVID-19 seroprevalence surveys, knowledge of serum-IgG responses to SARS-CoV-2 with a better understanding of patients who do not seroconvert, is imperative. This study aimed to describe serum-IgG responses to SARS-
Externí odkaz:
https://doaj.org/article/b31904ee65e44694afcdd204590b7df4
Autor:
Anu Kantele, Marianna Riekkinen, T Sakari Jokiranta, Sari H Pakkanen, Jukka-Pekka Pietilä, Anu Patjas, Mari Eriksson, Tamim Khawaja, Peter Klemets, Kati Marttinen, Heli Siikamäki, Anna Lundgren, Jan Holmgren, Agneta Lissmats, Nils Carlin, Ann-Mari Svennerholm
Publikováno v:
Journal of Travel Medicine.
Background No licensed human vaccines are available against enterotoxigenic Escherichia coli (ETEC), a major diarrhoeal pathogen affecting children in low- and middle-income countries and foreign travellers alike. ETVAX®, a multivalent oral whole-ce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c9d5b35492e7c78c5d1afeaf264fad5f
https://doi.org/10.1093/jtm/taad045
https://doi.org/10.1093/jtm/taad045